Neuroscience Institute of Schizophrenia and Allied Disordes (NISAD): 10 years of Australia's first virtual research institute

Australian and New Zealand Journal of Psychiatry

Volumn 41, Issue 1, 2007, Pages 78-88

  Draganic, Daren ^a   Catts, Stanley ^b   Carr, Vaughan ^c  

^a Neuroscience Institute of Schizophrenia and Allied Disorders   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Institute; Network; Psychosis; Research; Schizophrenia

Indexed keywords

ATTENTION; AUSTRALIA; AUTOPSY; AWARENESS; BRAIN; CLINICAL RESEARCH; COGNITION; CONCEPTUAL FRAMEWORK; DELUSION; DESCRIPTIVE RESEARCH; EMOTION; EVOKED AUDITORY RESPONSE; GENOMICS; HEALTH CARE ORGANIZATION; HUMAN; INFORMATION PROCESSING; INSTITUTIONAL CARE; MEDICAL RESEARCH; MENTAL FUNCTION; MENTAL HEALTH SERVICE; NARRATIVE; NEUROBIOLOGY; NEUROSCIENCE; NONHUMAN; ORGAN DONOR; PATIENT CARE; PSYCHOPHARMACOLOGY; PSYCHOSIS; PUBLIC HEALTH; REGISTER; RESOURCE MANAGEMENT; REVIEW; SCHIZOPHRENIA; SUBSTANCE ABUSE;

ACADEMIC MEDICAL CENTERS; AUSTRALIA; BIOMEDICAL RESEARCH; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MENTAL DISORDERS; NEUROSCIENCES; SCHIZOPHRENIA; USER-COMPUTER INTERFACE;

EID: 34248152276     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670601057783     Document Type: Review

References (99)

1. Loughland, CM, Carr, VJ and Lewin, TJ. (2001) The NISAD Schizophrenia Research Register: Why do we need a database of schizophrenia volunteers?. Aust N Z J Psychiatry, 35, pp. 660-667.
2. Loughland, CM, Carr, VJ, Lewin, TJ, Barnard, RE, Chapman, JL and Walton, JM. (2004) Potential sampling and recruitment source impacts in schizophrenia research. Psychiatry Res, 125, pp. 117-127.
3. Carr, VJ, Lewin, TJ and Barnard, RE (2002) Comparisons between schizophrenia patients recruited from Australian general practices and public mental health services. Acta Psychiatr Scand, 105, pp. 346-355.
4. Loughland, C., Lewin, T., Carr, V., Sheedy, J. and Harris, A. RBANS neuropsychological profiles within schizophrenia samples recruited from non-clinical settings. Schizophr Res
5. Garrick, T., North, A., Glaw, X. and Harper, CG. (2006) The diagnosis is critical for psychiatric brain banks: An inter-rater reliability study. Aust N Z J Psychiatry, 40, pp. 606-607.
6. Sarris, M., Garrick, TM, Sheedy, D. and Harper, CG. (2002) Banking for the future: An Australian experience in Brain Banking. Pathology, 34, pp. 225-229.
7. Boyes, M. and Ward, P. (2003) Brain donation for schizophrenia research: gift, consent and meaning. J Med Ethics, 29, pp. 165-168.
8. Azizi, L., Garrick, TM, Merrick, J. and Harper, CG. (2006) Brain donation for research: Strong support in Australia. J Clin Neurosci, 13, pp. 449-452.
9. Russell, SG, Loughland, CM, Tooney, PA, Scott, RJ, Lewin, TJ and Carr, V. (2005) The Hunter DNA Bank for Schizophrenia and Allied Disorders: A unique Australian resource facilitating genetic research into mental illness. Aust N Z J Psychiatry, 39, p. A68.
10. Thompson, PM, Vidal, C. and Giedd, JN (2001) Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci USA, 98, pp. 11650-11655.
11. Schall, U., Johnston, P. and Lagopoulos, J. (2003) Functional brain maps of Tower of London performance: A positron emission tomography and functional magnetic resonance imaging study. Neuroimage, 20, pp. 1154-1161.
12. Ward, PB, Schall, UA, Lagopoulos, J., Bender, S. and Little, CL. (2001) Functional brain imaging of increasing task difficulty in the Tower of London in patients with schizophrenia and healthy volunteers: An fMRI study. Neuroimage, 13, p. 1114.
13. Rasser, PE, Johnston, P. and Lagopoulos, J. (2005) Functional MRI BOLD response to Tower of London performance of first-episode schizophrenia patients using cortical pattern matching. Neuroimage, 26, pp. 941-951.
14. Schall, U., Johnston, P., Todd, J., Ward, PB and Michie, PT. (2003) Functional neuroanatomy of auditory mismatch processing: An event-related fMRI study of duration-deviant oddballs. Neuroimage, 20, pp. 729-736.
15. Schall, U., Johnston, P., Todd, J., Ward, PB and Michie, P. (2005) Functional brain imaging of auditory mismatch processing in schizophrenia. Schizophr Bull, 31, p. 433.
16. Michie, PT, Todd, J., Schall, U. and Karayanidis, F. (2005) Duration of illness and mismatch negativity in schizophrenia. World J Biol Psychiatry, 6, p. 52.
17. Matthews, NL, Todd, J., Cooper, G., Finnigan, S., Catts, S. and Michie, PT. (2006) Temporal processing in schizophrenia: Evidence for impairment across a range of time scales. Aust N Z J Psychiatry, 40, p. A116.
18. Richards, AL, Todd, J. and Michie, PT. (2006) Insensitivity to temporal context in schizophrenia. Aust N Z J Psychiatry, 40, p. A116.
19. Nicholson, R., Karayanidis, F., Poboka, D., Heathcote, A. and Michie, P. (2005) Electrophysiological components associated with anticipatory task-switching processes. Psychophysiology, 42, pp. 540-554.
20. Nicholson, R., Karayanidis, F., Bumak, E., Poboka, D. and Michie, P. (2006) ERPs dissociate the effects of switching task-sets and task-cues. Brain Res, 1095, pp. 107-123.
21. Karayanidis, F., Nicholson, R., Meem, L., Michie, P. and Schall, U. (2006) Switching between univalent task-sets in schizophrenia: ERP evidence of an anticipatory task-set reconfiguration deficit. Clin Neurophysiol, 117, pp. 2172-2190.
22. Clunas, NJ and Ward, PB. (2005) Auditory recovery cycle dysfunction in schizophrenia: A study using event related potentials. Psychiatry Res, 136, pp. 17-25.
23. Clunas, NJ and Ward, PB. (2005) Altered auditory recovery cycle function in schizophrenia and bipolar disorder: An ERP study. Schizophr Bull, 31, p. 451.
24. Loughland, CM, Williams, LM and Gordon, E. (2002) Visual scanpaths to positive and negative facial emotions in an outpatient schizophrenia sample. Schizophr Res, 55, pp. 159-170.
25. Loughland, CM, Williams, LM and Harris, AW. (2004) Visual scanpath dysfunction in first-degree relatives of schizophrenia probands: evidence for a vulnerability marker. Schizophr Res, 67, pp. 11-21.
26. Loughland, CM, Williams, LM and Gordon, E. (2002) Schizophrenia and affective psychosis show different visual scanning behaviour for faces: a trait verses state-based distinction. Biol Psychiatry, 52, pp. 338-348.
27. Williams, LM, Loughland, CM, Green, MJ, Harris, AWF and Gordon, E. (2003) Emotion perception in schizophrenia: An eye movement study comparing the effectiveness of risperidone vs. haloperidol. Psychiatry Res, 120, pp. 13-27.
28. Green, MJ, Williams, LM and Davidson, DJ. (2003) Visual scanpaths to threat-related faces in deluded schizophrenia. Psychiatry Res, 119, pp. 271-285.
29. Green, MJ, Waldron, JH and Coltheart, M. (2005) Eye movements reflect aberrant processing of social context in schizophrenia. Schizophr Bull, 31, p. 470.
30. Johnston, PJ, Katsikitis, M. and Carr, VJ. (2001) A generalised deficit can account for problems in facial emotion recognition in schizophrenia. Biol Psychol, 58, pp. 203-227.
31. Johnston, PJ, McCabe, K. and Schall, U. (2003) Differential susceptibility to performance degredation across categories of facial emotion: A model confirmation. Biol Psychol, 63, pp. 45-58.
32. Johnston, PJ, Stojanov, W., Devir, H. and Schall, U. (2005) Functional MRI of facial emotion recognition deficits in schizophrenia and their electrophysiological correlates. Eur J Neurosci, 22, pp. 1221-1232.
33. Johnston, PJ, Karayanidis, F. and Devir, H. (2006) Facial emotion processing in schizophrenia: No evidence for a negative emotion specific deficit using a differential deficit design. Psychiatry Res, 143, pp. 51-61.
34. Lagopoulos, J., Gordon, E. and Ward, P. (2006) Differential BOLD responses to auditory target stimuli associated with a skin conductance response. Acta Neuropsychiatr, 18, pp. 105-114.
35. Williams, LM, Brammer, MJ and Skerrett, D. (2000) The neural correlates of orienting: An integration of fMRI and skin conductance orienting. Neuroreport, 11, pp. 3011-3015.
36. Williams, LM, Phillips, ML and Brammer, MJ (2001) Arousal dissociates amygdala and hippocampal fear responses: Evidence from simultaneous fMRI and skin conductance recording. Neuroimage, 14, pp. 1070-1079.
37. Liddell, BJ, Brown, KJ and Kemp, AH (2005) A direct brainstem-amygdala-cortical 'alarm' system for subliminal signals of fear. Neuroimage, 24, pp. 235-243.
38. Williams, LM, Brown, KJ and Das, P. (2004) The dynamics of cortico-amygdala and autonomic activity over the experimental time course of fear perception. Cognitive Brain Res, 21, pp. 114-123.
39. Williams, LM, Das, P. and Liddell, B. (2005) BOLD, sweat and fears: FMRI and skin conductance distinguish facial fear signals. Neuroreport, 16, pp. 49-52.
40. Williams, LM, Das, P. and Harris, AWF (2004) Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry, 161, pp. 480-489.
41. Das, P., Kemp, AH and Liddell, BJ (2005) Pathways to fear perception: modulation of amygdala activity by thalamo-cortical systems. Neuroimage, 26, pp. 141-148.
42. Williams, LM, Das, P., Flynn, G. and Harris, AWF. (2005) 'Missing links': Loss of functional connectivity in the emotional brain systems in schizophrenia. Aust N Z J Psychiatry, 39, p. A22.
43. Malhi, GS, Lagopoulos, J., Sachdev, P., Mitchell, PB, Ivanovski, B. and Parker, GB. (2004) Cognitive generation of affect in hypomania: An fMRI study. Bipolar Disord, 6, pp. 271-285.
44. Malhi, GS, Lagopoulos, J. and Ward, PB (2004) FMRI of cognitive generation of affect in bipolar depression. Eur J Neurosci, 19, pp. 741-754.
45. Langdon, R., Corner, T., McLaren, J., Ward, PB and Coltheart, M. (2006) Externalizing and personalizing biases in persecutory delusions: The relationship with poor insight and theory of mind. Behav Res Ther, 44, pp. 699-713.
46. Langdon, R., Coltheart, M. and Ward, PB. (2006) Empathetic perspective-taking is impaired in schizophrenia: Evidence from a study of emotion attribution and theory of mind. Cognitive Neuropsychiatry, 11, pp. 133-155.
47. Langdon, R., Corner, T., McLaren, J., Coltheart, M. and Ward, PB. (2006) Attentional orienting triggered by gaze in schizophrenia. Neuropsychologia, 44, pp. 417-429.
48. McKay, R., Langdon, R. and Coltheart, M. (2006) The persecutory ideation questionnaire. J Nerv Ment Dis, 194, pp. 628-631.
49. McKay, R., Langdon, R. and Coltheart, M. (2005) Paranoia, persecutory delusions and attributional biases. Psychiatry Res, 136, pp. 233-245.
50. McKay, R., Langdon, R. and Coltheart, M. (2006) Need for closure, jumping to conclusions, and decisiveness in delusion-prone individuals. J Nerv Ment Dis, 194, pp. 422-426.
51. McKay, R., Langdon, R. and Coltheart, M. The defensive function of persecutory delusions: An investigation using the implicit association test. Cognit Neuropsychiatry
52. Tooney, PA, Au, GG and Chahl, LA. (2000) Localisation of tachykinin NK1 and NK3 receptors in the human prefrontal and visual cortex. Neurosci Lett, 283, pp. 185-188.
53. Weidenhofer, J., Yip, J., Zavitsanou, K., Huang, XF, Chahl, L. and Tooney, P. (2006) Immunohistochemical localisation of the NK1 receptor in the human amygdala: Preliminary investigation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 30, pp. 1313-1321.
54. Tooney, PA, Crawter, VC and Chahl, LA. (2001) Increased expression of tachykinin NK1 receptors in the prefrontal cortex in schizophrenia. Biol Psychiatry, 49, pp. 523-527.
55. Tooney, PA, Anderson, WB, Lynch-Frame, A. and Chahl, LA. (2005) The effects of haloperidol treatment on the distribution of NK1 receptor immunoreactive neurons in the guinea pig brain. Neurosci Lett, 383, pp. 155-159.
56. Dixon, G., Dissanaike, S. and Harper, CG. (2000) Parvalbumin-immunoreactive neurons in the human anteroventral thalamic nucleus. Neuroreport, 11, pp. 96-100.
57. Dixon, G. and Harper, CG. (2001) Quantitative analysis of glutamic acid decarboxylase-immunoreactive neurons in the anterior thalamus of the human brain. Brain Res, 923, pp. 39-44.
58. Dixon, G. and Harper, CG. (2004) No evidence for selective GABAergic interneuron deficits in the anterior thalamic complex of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 28, pp. 1045-1051.
59. Wheeler, DG, Dixon, G. and Harper, CG. (2006) No differences in calcium-binding protein immunoreactivity in the posterior cingulate and visual cortex: Schizophrenia and normal controls. Prog Neuropsychopharmacol Biol Psychiatry, 30, pp. 630-639.
60. Dixon, G., Garrick, T., Whiteman, I., Sarris, M., Sithamparanathan, S. and Harper, CG. (2004) Characterisation of GABAergic neurons within the human medial mamillary nucleus. Neuroscience, 127, pp. 365-372.
61. Tooney, PA and Chahl, LA. (2004) Neurons expressing calcium-binding proteins in the prefrontal cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 28, pp. 273-278.
62. Zavitsanou, K., Ward, PB and Huang, XF. (2002) Selective alterations of iontropic glutamate receptors in anterior cingulate cortex in schizophrenia. Neuropsychopharmacology, 27, pp. 826-833.
63. Newell, KA, Zavitsanou, K. and Huang, XF. (2005) Ionotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patients. Neuroreport, 16, pp. 1363-1367.
64. Zavitsanou, K., Garrick, T. and Huang, XF. (2004) Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 28, pp. 355-360.
65. Newell, KA, Deng, C. and Huang, XF. (2006) Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. Exp Brain Res, 172, pp. 556-560.
66. Zavitsanou, K. and Huang, XF. (2002) Decreased [3H] spiperone binding in the anterior cingulate cortex of schizophrenia patients: An autoradiographic study. Neuroscience, 109, pp. 709-716.
67. Newell, KA, Zavitsanou, K., Jew, SK and Huang, XF Alterations of muscarinic and GABA receptors in the posterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry
68. Zavitsanou, K., Katsifis, A., Mattner, F. and Huang, XF. (2004) Investigation of M1/M4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder and major depression disorder. Neuropsychopharmacology, 29, pp. 619-625.
69. Zavitsanou, K., Katsifis, A. and Huang, XF. (2005) M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders. Brain Res Bull, 65, pp. 397-403.
70. Zavitsanou, K. (2004) M1 receptor agonism, a possible treatment for cognitive deficits in schizophrenia. Neuropsychopharmacology, 29, pp. 1585-1586.
71. Deng, C. and Huang, XF. (2005) Decreased density of muscarinic receptors in the superior temporal gyrus in schizophrenia. J Neurosci Res, 81, pp. 883-890.
72. Deng, C. and Huang, XF. (2006) Increased density of GABA-A receptors in the superior temporal gyrus in schizophrenia. Exp Brain Res, 168, pp. 587-590.
73. Bowden, NA, Weidenhofer, J. and Scott, RJ (2006) Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia. Schizophr Res, 82, pp. 175-183.
74. Weidenhofer, J., Bowden, NA, Scott, RJ and Tooney, PA. (2006) Altered gene expression in the amygdala in schizophrenia: Upregulation of genes located in the cytomatrix active zone. Mol Cell Neurosci, 31, pp. 243-250.
75. Chetcuti, A., Adams, LJ, Mitchell, PB and Schofield, PR. (2006) Altered gene expression in mice treated with the mood stabilizer sodium valproate. Int J Neuropsychopharmacol, 9, pp. 267-276.
76. Duncan, CE, Chetcuti, A. and Schofield, PR. (2005) Identification of genes associated with schizophrenia using an animal model of antipsychotic drug action. Am J Med Genet Neuropsychiatr Genet, 138, p. 121.
77. Blair, IP, Chetcuti, AF and Badenhop, RF (2006) Positional cloning, association analysis, and expression studies provide convergent evidence that the cadherin gene FAT contains a bipolar disorder susceptibility allele. Mol Psychiatry, 11, pp. 372-383.
78. Clark, D., Dedova, I., Cordwell, S. and Matsumoto, I. (2006) A proteome analysis of the anterior cingulate cortex grey matter in schizophrenia. Mol Psychiatry, 11, pp. 459-470.
79. Iwazaki, T., McGregor, I. and Matsumoto, I. (2006) Protein expression profile in the striatum of acute methamphetamine-treated rats. Brain Res, 1097, pp. 19-25.
80. Karl, T., Duffy, L. and Schofield, P. (2005) Nrg1 knockout mice: An animal model for schizophrenia?. Aust N Z J Psychiatry, 39, p. A19.
81. Newson, P., Lynch-Frame, A., Roach, R., Bennett, S., Carr, V. and Chahl, LA. (2005) Intrinsic sensory deprivation induced by neonatal capsaicin treatment induces changes in rat brain and behaviour of possible relevance to schizophrenia. Br J Pharmacol, 146, pp. 408-418.
82. Schleimer, SB, Johnston, GAR and Henderson, JM. (2005) Novel oral drug administration in an animal model of neuroleptic therapy. J Neurosci Methods, 146, pp. 159-164.
83. Karl, T., Duffy, L., O'Brien, E., Matsumoto, I. and Dedova, I. (2006) Behavioural effects of chronic haloperidol and risperidone treatment in rats. Behav Brain Res, 171, pp. 286-294.
84. O'Brien, E., Dedova, I., Duffy, L., Karl, T. and Matsumoto, I. (2006) Effects of chronic risperidone treatment on the striatal protein profiles in rats. Brain Res, 1113, pp. 24-32.
85. Huang, XF, Deng, C. and Zavitsanou, K. (2006) Neuropeptide Y gene expression following olanzapine, clozapine and haloperidol administration in rats. Neuropeptides, 40, pp. 213-219.
86. Huang, XF, Han, M., Huang, X., Zavitsanou, K. and Deng, C. (2006) Olanzapine differentially affects 5-HT2A and 5-HT2C receptor mRNA expression in the rat brain. Behav Brain Res, 171, pp. 355-362.
87. Bois, TM du, Bell, W., Deng, C. and Huang, XF. (2005) A high n-6 polyunsaturated fatty acid diet reduces muscarinic M2/M4 receptor binding in the rat brain. J Chem Neuroanat, 29, pp. 282-288.
88. Bois, TM du, Deng, C., Bell, W. and Huang, XF. (2006) Dietary fatty acids differentially affect 5-HT2 receptor and transporter binding in the rat brain. Neuroscience, 139, pp. 1397-1403.
89. Cohen, M., Johnston, P. and Ehlkes, T. (2006) An fMRI study of cerebral activation differences between cannabis users and schizophrenia patients during the Tower of London task. Schizophr Res, 81, p. 300.
90. Monterrubio, S., Solowij, N., Meyer, BJ and Turner, N. (2006) Fatty acid relationships in former cannabis users with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 30, pp. 280-285.
91. Baker, A., Richmond, R. and Haile, M. Characteristics of smokers with a psychotic illness and implications for smoking interventions. Psychiatry Res
92. Baker, A., Bucci, S., Lewin, TJ, Richmond, R. and Carr, VJ. (2005) Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Res, 134, pp. 241-245.
93. Baker, A., Richmond, R. and Haile, M. (2006) Randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. Am J Psychiatry, 163, pp. 1934-1942.
94. Baker, A., Bucci, S., Lewin, TJ, Kay-Lambkin, F., Constable, PM and Carr, VJ. (2006) Randomised control trial of cognitive behaviour therapy for substance use disorders among people with a psychotic disorder. Br J Psychiatry, 188, pp. 439-448.
95. Russell, TA, Chu, E. and Phillips, ML (2006) A pilot study to investigate the effectiveness of emotion recognition remediation in schizophrenia using the Micro-Expression Training Tool. Br J Clin Psychol, 45, pp. 579-583.
96. Russell, TA, Green, M., Phillips, ML and Coltheart, M. (2005) Remediation of poor emotion processing in schizophrenia. Aust N Z J Psychiatry, 39, p. A41.
97. Andresen, R., Oades, L. and Caputi, P. (2003) The experience of recovery from schizophrenia: Towards an empirically validated stage model. Aust N Z J Psychiatry, 37, pp. 586-594.
98. Andresen, R., Caputi, P. and Oades, L. (2006) Stages of recovery instrument: Development of a measure of recovery from serious mental illness. Aust N Z J Psychiatry, 40, pp. 972-980.
99. Gorrell, J., Moss, B. and Ward, PB (2004) Pathways to care in early psychosis: Understanding treatment delay. Schizophr Res, 70, p. 137.